Implementation of Medicare Part D and statin use among the elderly population with diabetes

Journal of Pharmaceutical Health Services Research

Volumn 3, Issue 4, 2012, Pages 191-196

  Vaidya, Varun ^a   Blazejewski, Lucas ^a   Pinto, Sharrel ^a  

^a UNIVERSITY OF TOLEDO   (United States)

Author keywords

Diabetes; Elderly; Medicare Part D; Statin use

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG USE; EDUCATIONAL STATUS; ETHNICITY; FEMALE; GERIATRIC PATIENT; HEALTH CARE UTILIZATION; HEALTH STATUS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRESCRIPTION; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SOCIAL STATUS; TREND STUDY;

EID: 84869204949     PISSN: 17598885     EISSN: 17598893     Source Type: Journal    
DOI: 10.1111/j.1759-8893.2012.00098.x     Document Type: Article

References (19)

1. Howard BV etal. Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care 2006; 29: 391-397.
2. Schramm TK etal. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation 2008; 117: 1945-1954.
3. Haffner SM etal. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-234.
4. Cheng AY, Leiter LA. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Curr Opin Cardiol 2006; 21: 400-404.
5. Group HPSCS. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomized placebo-controlled trial. Lancet 2002; 360: 7-22.
6. Tjia J, Briesacher BA. Prescription drug benefits and use of guideline recommended medications by elderly Medicare beneficiaries with diabetes mellitus. J Am Geriatr Soc 2008; 56: 1879-1886.
7. Ko DT etal. Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox. JAMA 2004; 291: 1864-1870.
8. Brown AF etal. Income-related differences in the use of evidence-based therapies in older persons with diabetes mellitus in for-profit managed care. J Am Geriatr Soc 2003; 51: 665-670.
9. Federman AD etal. Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart disease. JAMA 2001; 286: 1732-1739.
10. Qato DM etal. Racial and ethnic disparities in cardiovascular medication use among older adults in the United States. Pharmacoepidemiol Drug Saf 2010; 19: 834-842.
11. Persell SD, Baker DW. Aspirin use among adults with diabetes: recent trends and emerging sex disparites. Arch Intern Med 2004; 164: 2492-2499.
12. Wexler DJ etal. Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes. Diabetes Care 2005; 28: 514-520.
13. Domino ME, Farley JF. Economic grand rounds: did Medicare Part D improve access to medications? Psychiatr Serv 2010; 61: 118-120.
14. Ketcham JD, Simon KI. Medicare Part D's effects on elderly patients' drug costs and utilization. Am J Manag Care 2008; 14(Suppl. 11): SP14-SP22.
15. Henry J. Kaiser Family Foundation. Data Update: Medicare Prescription Drug Coverage Among Medicare Beneficiaries. Menlo Park, CA: Henry J. Kaiser Family Foundation, 2006. www.kff.org/medicare/upload/7453.pdf (accessed 25 July 2012).
16. Basu A etal. Impact of Medicare Part D on the Medicare-Medicaid dual-eligible beneficiaries' precription utilization and expenditures. Health Serv Res 2008; 45: 133-151.
17. Shrank WH etal. The effect of transitioning to Medicare Part D drug coverage in seniors dually eligible for Medicare and Medicaid. J Am Geriatr Soc 2008; 56: 2304-2310.
18. Huskamp HA etal. Part D and dually eligible patients with netal illness: medication access problems and use of intensive services. Psychiatr Serv 2009; 60: 1169-1174.
19. Polinski JM etal. Changes in drug utilization and out-of-pocket costs associated with Medicare Part D implementation: a systematic review. J Am Geriatr Soc 2010; 58: 1764-1779.